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Abstract 
Amyloid fibrils are aggregated and precipitated forms of protein in which the protein exists in highly 
ordered, long, unbranching threadlike formations that are stable and resistant to degradation by 
proteases. Fibril formation is an ordered process that typically involves the unfolding of a protein to 
partially folded states that subsequently interact and aggregate through a nucleation-dependent 
mechanism. Here we report on studies investigating the molecular basis of the inherent propensity of the 
milk protein, kappa-casein, to form amyloid fibrils. Using reduced and carboxymethylated kappa-casein ( 
RCM kappa-CN), we show that fibril formation is accompanied by a characteristic increase in thioflavin T 
fluorescence intensity, solution turbidity, and beta-sheet content of the protein. However, the lag phase of 
RCM kappa-CN fibril formation is independent of protein concentration, and the rate of fibril formation 
does not increase upon the addition of seeds ( preformed fibrils). Therefore, its mechanism of fibril 
formation differs from the archetypal nucleation-dependent aggregation mechanism. By digestion with 
trypsin or proteinase K and identification by mass spectrometry, we have determined that the region from 
Tyr(25) to Lys(86) is incorporated into the core of the fibrils. We suggest that this region, which is 
predicted to be aggregation-prone, accounts for the amyloidogenic nature of kappa-casein. Based on 
these data, we propose that fibril formation by RCM kappa-CN occurs through a novel mechanism 
whereby the rate-limiting step is the dissociation of an amyloidogenic precursor from an oligomeric state 
rather than the formation of stable nuclei, as has been described for most other fibril-forming systems. 
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Amyloid fibrils are aggregated and 
precipitated forms of protein in which the 
protein exists in highly ordered, long, 
unbranching thread-like formations which 
are stable and resistant to degradation by 
proteases. Fibril formation is an ordered 
process that typically involves the unfolding 
of a protein to partially folded states that 
subsequently interact and aggregate through 
a nucleation-dependent mechanism. Here we 
report on studies investigating the molecular 
basis of the inherent propensity of the milk 
protein, κ-casein, to form amyloid fibrils. 
Using reduced and carboxymethylated κ-
casein (RCMκ-CN) we show that fibril 
formation is accompanied by a characteristic 
increase in thioflavin T fluorescence intensity, 
solution turbidity and β-sheet content of the 
protein. However, the lag-phase of RCMκ-
CN’s fibril formation is independent of 
protein concentration and the rate of fibril 
formation does not increase upon addition of 
seeds (pre-formed fibrils). Therefore, its 
mechanism of fibril formation differs from 
the archetypal nucleation-dependent 
aggregation mechanism. By digestion with 
trypsin or proteinase K and identification by 
mass spectrometry we have determined that 
the region from Tyr25 to Lys86 is incorporated 
into the core of the fibrils.  We suggest that 
this region, which is predicted to be 
aggregation prone, accounts for the 
amyloidogenic nature of κ-casein. Based on 
these data, we propose that fibril formation 
by RCMκ-CN occurs through a novel 
mechanism whereby the rate-limiting step is 
the dissociation of an amyloidogenic 
precursor from an oligomeric state, rather 
than the formation of stable nuclei as has 
been described for most other fibril-forming 
systems.  
Amyloid fibrils are ordered aggregates 
of a normally soluble peptide or protein. Their 
formation results from the ordered association of 
partially folded protein intermediates that have a 
propensity to adopt a β-sheet conformation. 
These intermediates expose greater 
hydrophobicity to solution which encourages 
their mutual association. Fibril nucleation and 
elongation may then occur through sequential 
addition of intermediates due to β-sheet stacking 
via a nucleation-dependent mechanism (1-3). 
Typically the fibrils formed are long, straight, 
thread-like structures that are unbranched, 6-12 
nm in diameter and may consist of two to six 
‘protofilaments’ twisted around a central core. 
They are often rigid, stable and resistant to 
degradation (e.g. from proteases and 
denaturants). 
Amyloid fibril formation is often 
associated with disease and the misfolding 
process is believed to be causative, or at least 
linked, to disease onset and progression (e.g. in 
Alzheimer’s and Parkinson’s diseases and 
various amyloidoses) (reviewed in (2,4)). 
However, amyloid fibril formation is not 
confined to disease-related proteins. Studies 
have shown that non-disease related proteins, 
even those that have a high α-helix content in 
their native state (5-8), can assemble into 
amyloid fibrils and this has led to the proposal 
that the amyloid state is a generic conformation 
accessible to all polypeptide chains under 
appropriate conditions (9). Whilst it may be true 
that all proteins are capable of forming fibrils 
given the right conditions, the composition and 
amino acid sequence of a protein profoundly 
affects its propensity to adopt such structures. 
Moreover, the tendency of a polypeptide chain to 
aggregate, rather than fold correctly, depends on 
a number of intrinsic factors including the 
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propensity for it to form β-strands, its 
hydrophobicity and overall net charge (10,11). 
It has been previously shown that the 
reduced and carboxymethylated form of the milk 
protein, κ-casein (RCMκ-CN), forms amyloid 
fibrils when incubated under conditions of 
physiological pH and temperature (12,13). 
Furthermore, we have shown that native (non-
reduced) κ-casein is also capable of forming 
fibrils under the same conditions (13) which is 
not surprising since reduction and 
carboxymethylation of the protein does not 
significantly alter its secondary or tertiary 
structure (12). From our previous studies, we 
concluded that κ-casein has an inherent 
susceptibility toward fibril formation, however, 
under physiological conditions in milk, this is 
kept in check by the action of the other caseins 
(αs and β), which are able to inhibit its 
fibrillation (13). Of physiological relevance, 
amyloid-like deposits have been found in bovine 
mammary glands within calcified stones known 
as corpora amylacea (14-16) and bundles of 
fibrils have also been reported in the cytoplasm 
of cells that surround these calcified deposits 
(17). These fibrils may result from the incapacity 
of other casein proteins to prevent amyloid 
formation by κ-casein.   
Casein is the principal component of 
milk micelles and is a heterogeneous mix of 
proteins that include αS1-, αS2-, β- and κ-casein. 
These proteins have been classified as 
intrinsically disordered (18,19) as they are 
extremely flexible, essentially unfolded and have 
relatively little secondary or tertiary structure 
under physiological conditions. Although the 
caseins themselves are relatively small, ranging 
in mass between 19 to 25 kDa, they are usually 
associated, with calcium and other ions, in milk 
micelles that have molecular masses from 1 X 
103 to 3 X 106 kDa (20). When purified from the 
other casein proteins, κ-casein in aqueous 
solution forms large spherical polymers with an 
average molecular mass of 1.18 MDa (21). 
These polymers are formed from smaller 
multimeric subunits (ranging from monomers to 
decamers) that result from intramolecular and 
intermolecular disulfide bonding (22). When 
completely reduced, κ-casein forms a self-
associating polymeric species (comprising 31 
monomers) in equilibrium with the monomeric 
form (23). It has been proposed that the 
monomeric form of the protein is a precursor for 
amyloid fibril formation (13). 
The inherent propensity for κ-casein to 
form amyloid fibrils may be reflective of the 
relatively unstructured nature of its monomeric 
form in solution. A theoretical energy minimized 
three-dimensional model of κ-casein proposed 
by Kumosinski et al. (24) suggests that the 
monomeric form of the protein can adopt a 
‘horse and rider’ configuration in which the legs 
of the horse are two sets of anti-parallel β-sheets 
(from Lys21 to Phe55), which are rich in 
hydrophobic side chains. It has been speculated 
that the putative anti-parallel β-sheet legs, due to 
their high degree of hydrophobicity and 
exposure to solution, may facilitate amyloid 
fibril formation by κ-casein (12).  
The capacity of RCMκ-CN to form 
fibrils in a short time frame under conditions of 
physiological temperature and pH and without 
the need for denaturants, make it an ideal system 
in which to study amyloid fibril formation. 
Moreover, the link between casein amyloid fibril 
formation, corpora amylacea and the 
intracellular fibril-like bundles identified in cells 
surrounding these deposits indicates that a more 
detailed understanding of the mechanism by 
which κ-casein forms fibrils is required. Here, 
we show that fibril formation by RCMκ-CN 
occurs through a unique mechanism whereby the 
rate-limiting step is the dissociation of an 
amyloidogenic precursor from an oligomeric 
state. Furthermore, we have identified the region 
of the protein incorporated into the core of the 
amyloid fibrils formed by RCMκ-CN and show 
that this region encompasses that predicted to 
adopt an anti-parallel β-sheet structure in the 
native form of the protein (24) thereby providing 
the basis behind its unique fibril-forming 
mechanism. These results help to explain how 
fibril formation by κ-casein is largely prevented 
in vivo. Similar mechanisms involving 
dissociation of an amyloidogenic precursor from 
its natural binding partner/oligomeric state are 
also likely to be important in other fibril-forming 
systems in vivo.  
 
Experimental Procedures 
 
Materials- Bovine milk κ-casein (SWISS PROT 
accession number P02668), without the N-
terminal 21 amino acid leader peptide, was 
purchased from Sigma Chemical Co. (St. Louis, 
MO, USA). The homogeneity of this protein was 
typically above 90% as assessed by gel 
electrophoresis and ion-exchange 
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chromatography. Further purification of the 
protein by ion-exchange chromatography 
showed that there was no change in the rate or 
degree of fibril formation in this sample 
compared to the protein supplied directly from 
Sigma (data not shown), indicating that the other 
minor components present did not influence the 
ability of reduced κ-casein to form fibrils. As 
such, we used the κ-casein without further 
purification in these studies. For the experiments 
described here the protein was reduced and 
carboxymethylated as described previously (12). 
The vector pRSETB (Invitrogen, Carlsbad, CA, 
U.S.A) containing the human α-synucleinA53T 
gene was a kind gift from Dr Roberto Cappai 
(University of Melbourne, Australia) and the α-
synucleinA53T protein was expressed and 
purified as described previously (25). Thioflavin 
T (ThT), 1,4-dithiothreitol (DTT), proteinase K 
(molecular biology grade) and β-
mercaptoethanol were obtained from Sigma. 
Trypsin (proteomics grade) was also purchased 
from Sigma and prepared at 1 mg/mL in HCl. 
Uranyl acetate was purchased from Agar 
Scientific (Stansted, UK). The concentration of 
κ-casein was determined by spectrophotometric 
methods using a Cary 5000 UV-Vis-NIR 
spectrophotometer (Varian, Melbourne, 
Australia) and an extinction coefficient of 0.95 
mL.mg-1cm-1 (26).  
 Thioflavin T and light scattering assays - The 
formation of amyloid fibrils by RCMκ-CN was 
monitored using an in situ ThT binding assay 
(27). The protein was incubated at 37 °C in 50 
mM phosphate buffer, pH 7.2, unless stated 
otherwise. Samples were incubated with 10 μM 
ThT in black μClear 96-microwell plates 
(Greiner Bio-One, Stonehouse, UK). The plates 
were sealed to prevent evaporation and the 
fluorescence levels were measured with a 
Fluostar Optima plate reader (BMG 
Labtechnologies, Melbourne, Australia) with a 
440/490 nm excitation/emission filter set.  Fibril 
formation was also monitored by light scattering 
at 340 nm using a Fluostar Optima plate reader. 
For each assay, samples were prepared in 
duplicate and the change in ThT fluorescence at 
490 nm or light scattering at 340 nm is presented 
in the figures. 
In the seeding experiments, RCMκ-CN 
(0.2 - 2.5 mg/mL) was incubated under the same 
conditions as described above, however, prior to 
the start of the incubation an aliquot of freshly 
prepared fibrils was added to the reaction such 
that both the amount and the concentration of 
RCMκ-CN in each sample was maintained. In 
some experiments the fibrils were sonicated for 
10 min prior to use. As a control for these 
experiments, α-synucleinA53T was incubated at 
37°C in 50 mM phosphate buffer containing 100 
mM NaCl, pH 7.4 and 10 μM ThT in a 
microtitre plate. Single timepoint ThT readings 
were taken for α-synucleinA53T during 
incubation and the microtitre plate was subjected 
to constant shaking (700 rpm) using a 
Thermostar microplate shaker (BMG 
Labtechnologies) between readings.  
Transmission electron microscopy (TEM) - 
Formvar and carbon-coated nickel electron 
microscopy grids (SPI supplies, Wester Chester, 
USA) were prepared by the addition of 2 μL of 
protein sample, washed with 3 x 10 μL of milli-
Q and negatively stained with 10 μL of uranyl 
acetate (2% w/v). Samples were viewed using a 
Philips CM100 transmission electron microscope 
(Philips, Eindhoven, Netherlands) at a 
magnification range of 10,500 - 96,000 using an 
80 kV excitation voltage. 
Circular dichroism - Circular dichroism (CD) 
spectra over a wavelength range of 190 nm to 
250 nm were acquired for samples of RCMκ-CN 
before and after fibril formation using a Jasco J-
180 spectropolarimeter (Jasco, Victoria, Canada) 
connected to a Jasco water bath using a cell with 
a 0.1 mm optical pathlength. Samples were 
prepared in 20 mM phosphate buffer, pH 7.2 and 
diluted with the same buffer to a final 
concentration of 0.2 mg/mL before obtaining the 
spectra. The spectra were obtained at 37°C. 
Solvent spectra were subtracted from the 
measured protein spectra and the results shown 
are the average of 5 scans.  
FTIR Spectra and Deconvolution Procedures - 
Samples of RCMκ-CN before and after fibril 
formation were analyzed in a Bruker 
BioATRCell II using a Bruker Equinox 55 
Fourier transform infrared spectrometer (MA, 
USA) equipped with a liquid nitrogen cooled 
mercury cadmium telluride detector and a silicon 
internal reflection element. For each spectrum, 
256 interferograms were co-added at 2 cm–1 
resolution, and the water background was 
independently measured and subtracted from 
each protein spectrum. Spectral contributions 
from water vapor were subtracted using the 
atmospheric compensation feature of the Bruker 
Opus software package.  The amide I region of 
the IR spectrum (1600 – 1700 cm-1) consists of a 
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series of overlapped component bands which 
arise from absorption by different secondary 
structural elements in proteins and peptides.  In 
order to deconvolve these spectra, second 
derivatives of the amide I region were taken to 
determine the peak positions of the component 
bands. Subsequently, these component bands 
within the original spectra were fitted to a fixed 
number of Gaussian functions (28) using the 
OriginPro 7.5 software package by OriginLab 
(MA, USA), where the heights, widths and 
positions of each band were optimized 
iteratively. 
Proteolytic cleavage of amyloid fibrils formed by 
RCMκ-CN - Prior to proteolysis, RCMκ-CN 
fibrils were formed by incubating in 25 mM 
ammonium bicarbonate buffer, pH 7.4, overnight 
at 37°C. The presence of fibrils was confirmed 
by TEM.  Limited proteolysis experiments were 
carried out by incubating native and fibrillar 
forms of RCMκ-CN with trypsin or proteinase 
K. Enzymatic digestions were performed at 37°C 
using enzyme-to-substrate ratios of 1: 100 (w/w) 
for trypsin and 1: 1000 (w/w) for proteinase K. 
The presence of amyloid fibrils following 
proteolysis was confirmed by TEM. At the end 
of the assay an aliquot of each sample was taken 
for SDS-PAGE analysis and the remainder used 
for MALDI-TOF MS analysis. For SDS-PAGE, 
aliquots were removed at various time intervals 
and the reaction stopped by mixing with an equal 
volume of reducing sample buffer (50 mM Tris-
HCl, pH 6.8, 4% w/v SDS, 2% v/v 2-
mercaptoethanol, 12% glycerol, 0.01% 
bromophenol blue). These samples were then 
heated to 95°C for 5 min before being loaded 
onto gels. Proteolysis products were analyzed 
using 15% or 20% acrylamide gels (v/v) and 
standard techniques (29). Analysis of the 
samples by TEM showed that the sample 
preparation for SDS-PAGE analysis was 
sufficient to disaggregate the fibrils. 
Mass spectrometry - An Ultraflex III MALDI-
TOF/TOF mass spectrometer (Bruker Daltonics, 
Bremen, Germany) was used for the analysis of 
intact protein and proteolytic cleaved peptides. 
The instrument was used in linear mode for 
peptides >6000 Da and in reflectron mode for 
smaller peptides. Linear mode was calibrated 
using protein calibration standard I (Bruker 
Daltonics). The protein mixture enables 
calibrations and testing in a mass range of 
approximately 3000 to 25000 Da with an error of 
approximately 100 ppm. Reflector mode was 
calibrated using peptide calibration standard II 
(Bruker Daltonics) which enables calibrations 
and testing in a mass range 500- 6000 Da to a 
mass accuracy greater than 50 ppm. 
Aliquots taken for analysis by mass 
spectrometry were firstly mixed with urea to a 
final concentration of 6 M and left overnight at 
room temperature in order to disaggregate the 
fibrils. The sample was then mixed with 
trifluoroacetic acid (TFA) to a final 
concentration of 0.1% (v/v), acidified with HCl 
(final pH< 4), before being taken up in a reverse 
phase column ZipTipC-18 (Millipore, Billerica, 
MA, USA). After washing with acetonitrile (5% 
v/v), containing 0.1% (v/v) TFA multiple times 
to remove any salt and urea present, the sample 
was then step-wise eluted with increasing 
concentrations of acetonitrile (20%, 30%, 40%, 
50% and 60% v/v in 0.1% v/v TFA). The 
proteinase resistant peptide of interest was eluted 
with 50% and 60% v/v acetonitrile. Samples 
were analyzed by MALDI-TOF/TOF MS in 
linear mode using 2,5-dihydroxybenzoic acid 
(2,5-DHB) as the matrix (5 g/L) in 50% v/v 
acetonitrile with 0.1% v/v TFA.  
To confirm this peptide matched the 
protease-resistant band identified by SDS-
PAGE, a tryptic in-gel digest was performed 
according to the method of Shevchenko (30) 
with the following modifications. The 
Coomassie blue-stained bands from the gel were 
cut with a sterile scalpel blade into small blocks 
and destained using 50 mM NH4HCO3 in 30% 
v/v acetonitrile. The blocks were rinsed and 
incubated overnight at 37°C with 10 ng/µL of 
trypsin in 5 mM NH4HCO3. The tryptic 
fragments were extracted from the gel pieces by 
sonicating the samples for 15 min with 50% v/v 
acetonitrile with 0.1% v/v TFA and then the 
extracted peptide solution was dried down to a 
final volume of approximately 5 µL using a 
vacuum centrifuge. The tryptic peptides were 
analyzed directly by MALDI-TOF MS in 
reflector mode using 4-HCCA (α-Cyano-4-
hydroxycinnamic acid) as the matrix. The 
identity of these peptides was confirmed by 
matching their observed masses to the expected 
masses of the in silico tryptic digest of the 
known κ-casein sequence using Biotools 3.0 
software (Bruker Daltonics).     
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Results 
 
Amyloid fibril formation by RCMκ-CN does not 
proceed by a standard nucleation-dependent 
mechanism. Firstly, RCMκ-CN was incubated at 
37°C at various concentrations (0 – 10 mg/mL) 
in 50 mM phosphate buffer, pH 7.2 and the 
increase in ThT binding (which is associated 
with fibril formation) was examined by an in situ 
assay (Fig 1A and B). We have previously 
observed that the presence of the ThT dye in this 
assay does not affect the rate or extent of fibril 
formation by RCMκ-CN or the morphology of 
the fibrils formed. For all the concentrations 
tested, we found that during the early phase of 
incubation (i.e. the first 30 min), there was an 
initial concentration-dependent decrease in the 
ThT fluorescence of the samples. We and others 
have shown that κ-casein is able to bind ThT in 
its native state (12,13) and we observed that this 
initial decrease in fluorescence intensity at the 
start of this assay was attributable to the 
temperature-dependence of the ThT fluorescence 
(an increase in temperature leading to a decrease 
in fluorescence intensity). Thus, as the samples 
were warmed from room temperature to 37°C 
the fluorescence intensity from ThT bound to the 
native state of the protein decreased. After this 
period, there was a concentration-dependent 
increase in ThT fluorescence which reached a 
maximum at 600 – 800 min. The presence of 
fibrils in these samples was confirmed by TEM. 
Since the rate of increase in ThT fluorescence 
was observed to be dependent on the protein 
concentration (Fig. 1A and B), we sought to 
determine the reaction rate for the formation of 
fibrils by RCMκ-CN. The apparent reaction 
order can be determined according to the 
equation lnV = A + n lnC, where V is the initial 
reaction rate, C is the protein concentration and 
n is the apparent reaction order. The plot of the 
log of the protein concentration against the log 
of the initial reaction rate (Fig 1C), gave a slope 
(n) of 1.13 ± 0.15, indicating that the rate of 
increase in ThT fluorescence for RCMκ-CN 
follows an apparent first-order kinetic 
mechanism in relation to the protein 
concentration.   
We also monitored the incubation of 
RCMκ-CN by a light scattering assay, which did 
not involve ThT (Fig. 1D). When RCMκ-CN (0 - 
10 mg/mL) was incubated under the same 
conditions as for the ThT assay there was a 
concentration-dependent increase in light 
scattering that was associated with fibril 
formation. Interestingly, both the ThT in situ 
(Fig. 1A and B) and light scattering (Fig. 1D) 
data showed no evidence of a concentration-
dependent variation in the lag phase associated 
with fibril formation, an attribute that is a 
component of a nucleation-dependent 
mechanism of aggregation (such as has been 
described for most amyloid fibril-forming 
systems) (3). Even when the protein was 
incubated at lower temperatures, e.g. 32°C (Fig. 
1E) and 27°C (data not shown), the lag phase of 
the increase in ThT fluorescence was very short 
(i.e. < 30 min) and concentration independent. 
According to a nucleation-dependent 
aggregation mechanism, the rate-limiting step of 
fibril formation is the generation of stable nuclei, 
the rate of which is limited by the protein 
concentration. As such, the length of the lag 
phase of conversion of the protein to amyloid 
fibrils depends dramatically on the concentration 
of the protein (3). The clear absence of a 
concentration-dependent lag phase associated 
with fibril formation by RCMκ-CN suggested 
that the mechanism by which it forms fibrils may 
differ from that typically reported for other 
systems.  
We also tested whether adding 
preformed fibrils (seeds) to RCMκ-CN (2.5 
mg/mL) incubated at 37°C increased the rate of 
fibril formation, since in a nucleation-dependent 
mechanism, addition of exogenous seeds 
bypasses the need for nucleus formation, which, 
as discussed above, is typically considered to be 
the rate-limiting step in the aggregation process. 
However, addition of seeds (0.5 – 10.0% w/w) 
had no effect on the length of the lag phase or 
the rate of increase in ThT fluorescence, either at 
32°C (data not shown) or 37°C (Fig. 1F). Pre-
formed fibrils that were sonicated prior to 
addition also had no effect on RCMκ-CN fibril 
formation (data not shown). Similar results were 
found when the protein was incubated at 37°C at 
0.2 mg/mL and the reaction was seeded (10.0% 
w/w) with preformed fibrils (data not shown). In 
contrast, seeding (0.5 – 2.0% w/w) a sample of 
α-synucleinA53T (2 mg/mL), the Parkinson’s 
disease related fibril-forming protein which has 
been shown to form fibrils through a classic 
nucleation-dependent mechanism, dramatically 
increased the rate of fibril formation and 
decreased the lag phase of the reaction (Fig, 1F – 
inset). Together, these data suggest that the rate 
of fibril formation by RCMκ-CN is not limited 
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by the formation of stable nuclei as is found in 
most nucleation-dependent mechanisms of 
aggregation, but, instead is dependent on steps 
that precede the formation of nuclei, for example 
the dissociation of an amyloidogenic precursor 
from its oligomeric state.  
Monitoring the changes in RCMκ-CN before and 
after fibril formation by spectroscopic methods - 
Since RCMκ-CN has an inherent propensity to 
form fibrils when incubated under conditions of 
physiological pH and temperature, we 
investigated structural changes in RCMκ-CN 
that occur during the process of amyloid fibril 
formation to see if these would help to explain 
its amyloidogenic nature. RCMκ-CN (1 mg/mL) 
was incubated under conditions whereby it 
readily forms fibrils, i.e. 50 mM phosphate 
buffer, pH 7.2 at 37°C for 1000 min, and the 
presence of fibrils was confirmed by ThT 
fluorescence and TEM.  Far-UV circular 
dichroism (CD) spectroscopy (Fig. 2A), used to 
probe the secondary structural changes that 
accompany RCMκ-CN fibril formation, showed 
that freshly prepared RCMκ-CN gives a 
spectrum with a maximum negative molar 
ellipticity at 200 nm and shoulder at 215 nm, 
indicative of a predominately random coil 
protein and consistent with CD spectra of the 
protein reported previously (12). Following 
incubation under fibril-forming conditions, the 
CD spectrum of RCMκ-CN was red shifted such 
that the maximum negative molar ellipticity was 
at 203 nm and was decreased in intensity, and 
the shoulder at 215 nm was increased indicating 
that upon fibril formation there is a loss in 
random coil and an increase in β-sheet structure 
compared to the native protein. Similarly, FTIR 
analysis of the protein before and after fibril 
formation showed an increased β-sheet content 
in the fibrillar form of the protein (Fig. 2C). The 
shift in the amide I maximum to lower 
wavenumbers (from 1645 cm-1 to 1635 cm-1) 
suggests that there is significant structural 
reorganization during fibril formation involving 
an increase in β-sheet structure (31). From the 
deconvolved data (Fig. 2D), showing the 
individual component bands of the spectra (32), 
an increase in the band at ca. 1625 cm-1 and the 
development of bands at 1639 cm-1 and 1677 cm-
1 following fibril formation is attributable to the 
increase in β-sheet content in the sample. There 
was a corresponding decrease in bands at ca. 
1669 cm-1 and 1685 cm-1 attributed to turns and 
bends, while the magnitude of the band 
corresponding to disordered structure (1648 - 
1653 cm-1) was largely unchanged. Overall, the 
deconvolved FTIR data indicated a ~2.4-fold 
increase in the amount of β-sheet in RCMκ-CN 
following fibril assembly (from 17 to 41%) 
which is primarily derived from the loss of turns 
and bends present in the non-fibrillar form of the 
protein (Table 1).  
Identification of the protease-resistant core 
region of fibrils formed from RCMκ-CN - Our 
data suggest that the critical, rate-limiting step in 
amyloid fibril formation by RCMκ-CN is the 
dissociation of a precursor that is highly 
amyloidogenic and readily incorporated into pre-
fibrillar nuclei. Thus, we sought to identify the 
region of the protein incorporated into the core 
of the amyloid fibrils formed by RCMκ-CN in 
order to investigate whether this region showed 
characteristics of being highly amyloidogenic. In 
order to identify the core region of these fibrils 
we performed proteolysis experiments on native 
(N) and fibrillar (F) forms of the protein. In the 
absence of trypsin, RCMκ-CN derived from 
fibrils was observed as a full-length protein (19 
kDa) by SDS-PAGE. Addition of trypsin (1:100 
w/w ratio of substrate: trypsin) to native RCMκ-
CN resulted in its rapid proteolysis in less than 
30 min, generating small peptide fragments of 
less than 1 kDa (Fig. 3A). In contrast, fibrillar 
RCMκ-CN was much more resistant to 
degradation, such that, even following 4 hr of 
incubation with trypsin, a protease-resistant 
peptide of ~7 kDa was still evident by SDS-
PAGE. Following proteolysis with trypsin, 
fibrils with a similar morphology to those 
present before digestion were observed by TEM 
(Fig. 3B - C).   
Similar results were obtained when 
proteinase K was used in place of trypsin (Fig. 
4A), i.e. native RCMκ-CN was degraded by 
proteinase K into small peptide fragments 
whereas the fibrillar form was resistant to 
proteolytic degradation. After 4 hr of incubation 
of fibrillar with RCMκ-CN with proteinase K, 
four peptide bands were observed by SDS-
PAGE at 18, 15, 10 and 8 kDa. Following 
digestion with proteinase K, amyloid fibrils were 
still observed by TEM (Fig. 4B-C).  
We identified the protease-resistant core 
region of these amyloid fibrils by mass 
spectrometry. Since digestion with trypsin 
produced a smaller protease-resistant peptide 
fragment compared to proteinase K, we used this 
treatment in order to identify the protease-
resistant core. Following disaggregation of the 
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trypsin-treated fibrils, we purified the resultant 
peptide and subjected it to MALDI-TOF MS. 
The peptide was seen as a [M+H]+ ion at 7207.66 
Da in the spectrum (Fig. 5A) and thus its mass 
matched that of the peptide identified by SDS-
PAGE (see Fig. 3A). A number of smaller 
tryptic fragments were also identified that 
matched fragments generated when the native 
form of the protein was treated with trypsin (data 
not shown). Based on its mass, the identity of 
this tryptic fragment could not be 
unambiguously assigned: it could correspond to 
fragment κ-casein25-86 or κ-casein35-97 (Table 2). 
We confirmed the identity of the peptide by 
performing in-gel tryptic digestion of the band 
identified by SDS-PAGE and analyzing the 
fragments by MALDI-MS/MS. Three peaks with 
m/z ratios of 4009.90, 1980.03 and 1251.70 (Fig 
5B) were identified that matched to tryptic 
fragments of κ-casein35-68, κ-casein69-86, and κ-
casein25-34 respectively (Table 2), and thus 
correspond to fragments of the κ-casein25-86 
peptide. The sequence identity of these in-gel 
tryptic fragments was confirmed by tandem mass 
spectrometry. The peaks with lower m/z ratios in 
the spectrum arose from further fragmentation of 
these peptide fragments. 
We also confirmed that the same region 
of the protein was resistant to proteolytic 
degradation by proteinase K by performing an 
in-gel digest of the bands identified by SDS-
PAGE (see Fig. 4A) and analyzing the fragments 
by MALDI-MS/MS (data not shown). Fragments 
corresponding to κ-casein17-111 and κ-casein17-86 
were identified from the 10 kDa and 8 kDa 
bands respectively (Table 2). Both of these 
fragments encompass the region identified by 
trypsin proteolysis of the fibrils. Similar tryptic 
fragments were identified from the 18 kDa and 
15 kDa bands and therefore these higher 
molecular mass bands incorporate the same 
protease-resistant region of κ-casein and 
represent larger peptides that were not fully 
digested by the proteinase K treatment.   
 Correlation of the protease-resistant core 
region of fibrils formed by RCMκ-CN with 
theoretical predictions on the structure and 
fibril-forming propensity of κ-casein - Whilst κ-
casein is generally classified as an intrinsically 
disordered protein (18,19), previous three-
dimensional modelling (24) indicates that it can 
sample defined conformations, a finding that is 
supported by our CD and FTIR data (see Fig. 2).  
We have employed two independent disorder-
predicting algorithms to assess the regions of the 
κ-casein that are likely to fold into a well-
defined conformation, and therefore facilitate 
fibril formation (Fig. 6). Analysis with the VL-
XT algorithm using PONDR (33,34) indicated 
that, whilst almost half of the residues in the 
protein are predicted to be disordered (44%), the 
region Lys24-Pro64 is the most likely to adopt an 
ordered conformation. A similar region of the 
protein (Tyr30-Gln89) was predicted to fold into a 
defined conformation using the FoldIndex 
algorithm (35,36). Both these regions of 
predicted order therefore correlate very well with 
the region identified herein as being incorporated 
into the fibrillar core of fibrils formed by RCMκ-
CN (Tyr25-Lys86) suggesting that this region is 
likely to adopt the β-sheet conformation 
predicted by the previous modelling work (24).   
An examination of so-called 
“amyloidogenic domains” within a number of 
amyloid-forming proteins has led to the 
development of algorithms to predict 
aggregation-prone regions. We have used two 
such algorithms to examine the regions of κ-
casein predicted to be the most aggregation 
prone; (1) the algorithm TANGO (37) indicates 
these to be residues Ile28-Leu32 and Ile73-Leu79 
and, (2) a modified version of the Zyggregator 
algorithm (38) (Tartaglia et al., in preparation), 
also predicts regions of significant aggregation 
propensity between Tyr25-Gln29 and Leu74-Ser80 
(Fig. 6). κ-Casein also contains two regions 
(Tyr38-Gln44 and Thr121-Ala126) that match the six 
amino acid sequence pattern proposed by Lopez 
de la Paz and Serrano (39) to identify 
amyloidogenic stretches within proteins, 
however, the latter is preceded by a proline 
residue at position 120 which was found to be an 
“amyloid breaker”. Hence, these predictive 
methods correlate well with the protease-
resistant fragment (Tyr25-Lys86) identified in this 
study, which includes at least two regions of 
high aggregation propensity, encompassing 
residues Tyr25-Gln44 and Ile73-Ser80.  
 
Discussion 
 
Fibril formation by RCMκ-CN does not follow a 
simple nucleation-dependent mechanism - We 
have previously shown that in its native state κ-
casein has an inherent propensity to form 
amyloid fibrils when incubated under conditions 
of physiological pH and temperature in vitro 
(13). The formation of fibrils is enhanced by 
reduction of its disulfide bonds, however, this is 
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not attributable to significant secondary or 
tertiary structural changes in the protein upon 
reduction (12). As a result, we have used RCMκ-
CN in these studies since it forms fibrils much 
more readily than the non-reduced ‘native’ form 
(13) and we attribute this primarily to the 
absence of disulfide bonds, thereby increasing 
the pool of dissociated species in solution that is 
available to form fibrils. 
The key to understanding the rate of 
amyloid formation involves the identification of 
the rate-determining step in the overall process. 
Amyloid fibril formation is generally considered 
to proceed via a nucleation-dependent 
mechanism in which the slow step is the 
formation of an ordered, stable nucleus (Fig. 7) 
(3). The time required for the formation of this 
nucleus corresponds to a lag phase of 
polymerization, which is strongly protein 
concentration-dependent. In this scheme, the lag 
phase can be shortened by addition of preformed 
nuclei (seeds) to the reaction mix, which 
overcomes the time required for the formation of 
these seeds. Since fibril elongation also occurs 
from these added nuclei, the rate of fibril 
formation is also increased by seeding in a 
simple nucleation-dependent model (with the 
increase in rate being proportional to the amount 
of seeds added). In this study we have shown 
that RCMκ-CN fibril formation appears to be 
regulated by a novel mechanism, i.e. not the 
formation of a stable nucleus as is the case in a 
simple nucleation-dependent model. We have 
three distinct lines of evidence that have led us 
to this conclusion. Firstly, the lag phase of fibril 
formation is independent of the protein 
concentration (Fig. 1A, B and D) suggesting that 
steps preceding the formation of a nucleus are 
significant in the reaction mechanism. Secondly, 
this preceding step is rate-limiting and follows 
an approximate first-order reaction mechanism 
(Fig. 1C) with respect to the protein 
concentration. Thirdly, addition of exogenous 
seeds to the reaction did not affect either the rate 
or lag phase of fibril formation (Fig. 1F).  
Together these data are consistent with a 
model in which the dissociated form of the 
protein is the precursor to fibril formation. 
Moreover, the dissociation of this amyloidogenic 
species from an oligomeric state is the rate-
limiting step to fibril formation by RCMκ-CN 
(Fig. 7). This dissociation step therefore limits 
the supply of species to form stable nuclei and 
the supply of precursor to the growing fibril 
during its elongation phase. That the formation 
of a stable nucleus is not rate-limiting accounts 
for the lack of protein concentration-dependence 
on the lag phase of polymerization, as the 
dissociation rate would be independent of 
protein concentration. Such a model also 
explains the protein concentration-dependence 
on the rate of fibril formation but the lack of 
effect on the rate and lag phase of fibril 
formation of adding preformed seeds to the 
reaction mix.  
Thus, the precursor to fibril formation is 
the dissociated species rather than the oligomeric 
form of the protein. The reasoning for this is 
two-fold. Firstly, seeding of the reaction with up 
to 20% w/w preformed fibrils did not have an 
effect on the rate of fibril formation. If the 
oligomer were the precursor to fibril formation 
than it is foreseeable that seeding at low 
concentrations (i.e. 0.5 – 2% w/w) would not 
have a significant effect on the lag phase or rate 
of fibril formation since the number of seeds 
would be relatively small compared to the 
number of pre-existing nuclei (in the form of 
oligomers). However, at higher concentrations 
the number of seeds would be relatively high and 
so one would expect to see an observable change 
in the lag phase and rate of fibril elongation 
since the number of amyloidogenic oligomers 
would not be limiting. Secondly, it is more likely 
that the dissociated species would enable the 
ordered aggregation required for fibril formation 
to proceed since it would expose the 
hydrophobic ‘legs’ that we have identified make 
up the protease-resistant core of the fibrils (see 
below). In contrast, in the oligomeric form of the 
protein the hydrophobic regions are thought to 
be internally buried (23,40), which would limit 
their ability to associate to form fibrils.  
In the majority of studies describing 
fibril formation by a specific precursor protein, 
aggregation has been shown to involve solution 
conditions that disrupt the native structure and 
therefore facilitate unfolding. Thus, a critical 
component of the general model for amyloid 
fibril formation is the requirement for the protein 
to unfold, at least partially, as a precursor to 
amyloid nucleation (1) (see Fig. 7). However, for 
many systems involved with disease (e.g. 
Alzheimer’s, Parkinson’s), the peptides and 
proteins that have been found to aggregate adopt 
essentially unstructured conformations in their 
normal biological state, i.e. they are ‘natively 
unfolded’ (10). Thus, aggregation does not need 
to be preceded by the unfolding of a globular 
protein, but rather, may proceed by direct self-
8 
assembly of the particular protein or peptide 
from an ensemble of unstructured conformations 
(10). Moreover, whilst dissociation of a protein 
from an oligomeric form can generate an 
amyloid precursor due to the change in solution 
conditions (e.g. for acid denaturation of the 
transthyretin tetramer to form monomers (41)), 
the possibility that amyloid fibril formation 
primarily occurs due to a ‘native’ amyloidogenic 
species dissociating from its binding partner or 
parent oligomer, under physiological conditions, 
has not been fully explored. 
In the case of κ-casein, it is reasonable 
to speculate that the generation of the 
amyloidogenic intermediate may simply involve 
dissociation from its oligomeric state, i.e. 
quaternary structure destabilization. In the 
absence of the other casein proteins, monomeric 
forms of κ-casein are in dynamic equilibrium 
with a large oligomeric species (22). Treatments 
known to increase the rate of dissociation, such 
as heat and reduction, increase the rate of 
amyloid fibril assembly (13). It remains to be 
determined the extent of unfolding undergone by 
these dissociated forms in the generation of an 
amyloidogenic precursor. However, it is likely to 
be limited, since modelling (24) suggests that the 
dissociated κ-casein monomer samples a 
structural conformation that is an ideal β-sheet 
containing precursor for fibril formation, 
negating the need for further unfolding.  
The rate-limiting species formed during amyloid 
fibril formation by RCMκ-CN is highly 
amyloidogenic - As part of our proposed model 
for the mechanism by which RCMκ-CN forms 
fibrils, the dissociated species is highly 
amyloidogenic, and so is readily incorporated 
into nuclei or growing fibrils when it becomes 
available. Thus, there is no free pool of this 
amyloidogenic species available to be 
incorporated into exogenous seeds as occurs in 
the simple nucleation-dependent model. We 
therefore sought to identify the regions of the 
protein incorporated into the protease-resistant 
core of fibrils formed by RCMκ-CN and 
investigated whether these help to explain its 
amyloidogenic nature. Our findings indicate that 
the region of RCMκ-CN from Tyr25 to Lys86 
represents the protease-resistant β-sheet core of 
amyloid fibrils formed by κ-casein. This region 
correlates well with that predicted to fold into a 
well-defined conformation by protein disorder 
algorithms and is aggregation prone (see Fig. 6). 
Whilst κ-casein is regarded as a natively 
unstructured protein, since its monomer adopts 
native molten-globule-like states, i.e. it has ill-
defined tertiary structure whilst retaining some 
secondary structural elements (19), theoretical 3-
D modelling of the protein has suggested that it 
may sample a “horse and rider” conformation 
(24). In this model, the region from Lys21 to 
Phe55 is proposed to adopt an anti-parallel β-
sheet formation in which the β-sheets are 
separated by proline turns (24). These ‘legs’, due 
to their high degree of hydrophobicity and 
exposure, would make an ideal site for sheet-
sheet interactions. Under physiological 
conditions such interactions would presumably 
occur with hydrophobic domains of other 
caseins, facilitating its incorporation into 
oligomeric species such as milk micelles. 
However, this region of the protein would also 
favor β-sheet stacking with other κ-casein 
subunits, and therefore facilitate amyloid fibril 
assembly.  
The assembly of fibrils formed from RCMκ-CN - 
Our studies show that a significant portion of the 
full-length protein is protected from proteolytic 
cleavage once it has adopted the fibrillar 
conformation, even when a relatively non-
specific protease such as proteinase K is used for 
the digestion. This is similar to what has been 
reported for other amyloid forming systems, e.g. 
up to 89 residues (residues 10-99) of β2-
microglobulin were found to be resistant to 
degradation by pepsin (42). It is highly likely 
that a single κ-casein monomer may contribute 
more than one β-strand to the fibril structure, in 
a similar manner to that shown for the amyloid 
beta peptide (Aβ1-40) (43) and the C-terminal 
fragment of the HET-s protein (44). Moreover, 
as the protease-resistant region of fibrillar κ-
casein is continuous, the loops joining these 
strands are unlikely to be solvent exposed. 
Further structural studies of fibrils formed by κ-
casein are required to confirm these proposals.  
It was unexpected that treatment with trypsin (a 
relatively specific protease) was able to cleave 
closer to the core of the amyloid fibrils than 
proteinase K (a relatively non-specific protease). 
This may reflect differences in the residue 
accessibility of the two proteases (due to packing 
of the fibrils) due to variations in their size and 
mode of action.  
Upon fibril assembly, κ-casein 
undergoes structural rearrangement within the 
protein, particularly to the region predicted to 
have a high propensity to form β-sheet (24). 
Indeed, our spectroscopic data indicate that, 
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whilst some regions of the protein are not 
involved in fibril formation (as assessed by 
NMR spectroscopy – H Ecroyd, DM Williams 
and JA Carver, unpublished results), others 
undergo major rearrangements, leading to a 
significant increase in the β-sheet content of the 
protein (as shown by FTIR spectroscopy, see 
Fig. 2 and Table 1). Moreover, whilst we suggest 
that the inherent propensity for κ-casein to form 
amyloid fibrils originates from regions of the 
monomeric state that facilitate β-sheet stacking, 
the differences in the component bands of the 
amide I region of the FTIR spectra attributable to 
β-sheet suggest that the β-sheet domains in the 
native and fibrillar forms are structurally 
dissimilar. Thus, amyloid fibril growth does not 
simply involve the direct stacking of native β-
sheets from individual precursors, but instead is 
most likely preceded by a reorganization of these 
regions, as has been suggested for other β-sheet 
containing proteins (45).  
Conclusions - Here we show that fibril formation 
by RCMκ-CN is not governed by the simple 
nucleation-dependent model that has been 
proposed for most other amyloid fibril-forming 
systems studied to date (Fig. 7). Instead, we 
propose that the rate of fibril formation by 
RCMκ-CN is limited by the dissociation of an 
amyloidogenic precursor from an oligomeric 
state (Fig. 7). In milk, the amount of this 
amyloidogenic species would be very low 
because of the interaction of κ-casein with itself 
(e.g. via intermolecular disulfide bonding) and 
with the other caseins in milk (e.g. in milk 
micelles). Nonetheless, the proteinaceous 
deposits found within corpora amylacea of 
mammary tissue have been shown to be amyloid 
in nature (14-16) and peptides corresponding to 
casein fragments have been isolated from within 
these amyloid-like deposits (46,47). Moreover, 
intracellular fibrillar bundles have also been 
identified in epithelial cells that surround the 
deposits of corpora amylacea (17,48). These are 
sites at which casein synthesis and secretion is 
high and the reducing environment of the cell 
would favor reduced forms of these proteins. 
Thus, it is possible that the dissociation of 
amyloidogenic precursors of κ-casein from milk 
micelles does occur under some circumstances, 
resulting in fibrillar deposits within these tissues. 
That amyloidoses associated with κ-casein fibril 
formation are not more prevalent in vivo is 
probably a testament to the interaction between 
the casein proteins, which prevent the release of 
this κ-casein amyloidogenic precursor and 
thereby inhibit large-scale κ-casein fibril 
formation through their chaperone-like activity 
(13,49).  
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Figure legends 
 
Fig. 1. Fibril formation of RCMκ-CN (0 - 10 mg/mL) as monitored by (A and B) ThT 
fluorescence and (D) light scattering at 340 nm. Samples were incubated in 50 mM phosphate buffer, 
pH 7.2 at 37°C and monitored over time. (C) A plot of the ln[RCMκ-CN] against ln[reaction rate]. 
The reaction rate was determined from the initial rate of increase in ThT fluorescence from data such 
as shown in (A and B). In (D), the initial rate of the increase in light scattering has been extrapolated 
to determine the lag phase of the reaction (dotted lines). (E) The effect on ThT fluorescence of 
decreasing the temperature to 32°C on fibril formation of RCMκ-CN (0 - 10 mg/mL). (F) The effect 
of seeding on the rate of fibril formation by RCMκ-CN. A sample of RCMκ-CN (2.5 mg/mL) was 
incubated in 50 mM phosphate buffer, pH 7.2 at 37°C with or without the addition of preformed 
fibrils (seeds) at a 0.5% or 5.0% w/w ratio (Note – the seeded curves overlay each other in the graph). 
Inset – the addition of seeds to a sample of α-synucleinA53T incubated at 2 mg/mL in 50 mM 
phosphate buffer, 100 mM NaCl, pH 7.4 at 37°C with shaking (● – no seed added, ○- 0.5% w/w seed 
added, ▼ – 2.0% w/w seed added).    
 
Fig. 2. Analysis of RCMκ-CN before (t = 0 min) and after (t = 1000 min) incubation under 
conditions which promote amyloid formation fibril by (A) CD and (B) FTIR spectroscopy. 
Deconvolved FTIR data showing the individual component bands of the spectra for (C) RCMκ-CN 
before (t = 0 min) and (D) RCMκ-CN after (t = 1000 min) incubation.  
 
Fig. 3. RCMκ-CN fibrils have a protease-resistant core. (A) SDS-PAGE analysis of native 
(N) and fibrillar (F) RCMκ-CN following treatment with trypsin for 0, 0.5, 1, 2 and 4 hr. 
Transmission electron micrographs of RCMκ-CN before (B) and after (C) incubation with trypsin for 
4 hr. Scale bar represents 500 nm. 
 
Fig. 4. Digestion of RCMκ-CN fibrils with proteinase K. (A) SDS-PAGE analysis of native 
(N) and fibrillar (F) RCMκ-CN following treatment with proteinase K for 0, 0.5, 1 and 2 hr. The 10 
kDa and 8 kDa bands identified by mass spectrometry and shown in Table 1 are denoted by (*). 
Transmission electron micrographs of RCMκ-CN before (B) and after (C) incubation with proteinase 
K for 4 hr. Scale bar represents 200 nm. 
 
Fig. 5. Identification of the protease-resistant core of amyloid fibrils formed by RCMκ-CN 
using mass spectrometry. (A) MALDI-TOF MS spectrum of peptide fragments present following 
treatment of RCMκ-CN fibrils with trypsin and their subsequent disaggregation and elution with 60% 
acetonitrile using ZipTip clean-up. (B)  MALDI-TOF spectrum of the tryptic peptides from the in-gel 
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digest obtained from the Coomassie blue stained SDS-PAGE band that was identified following 
treatment of RCMκ-CN fibrils with trypsin. 
 
Fig. 6. A summary of the key regions of κ-casein with regard to its amyloid fibril-forming 
ability. The diagram indicates the regions of the protein predicted to form β-sheet by 3D-modelling 
(24), the protease-resistant fibrillar core fragments generated by digestion with proteinase K and 
trypsin and identified by mass spectrometry, the region of the protein predicted to be ordered by the 
algorithms PONDR (33,34) and FoldIndex (35,36), the most amyloidogenic regions of the protein as 
predicted by TANGO (37) and a modified version of Zyggregator (38) (Tartaglia et al., in 
preparation), and the region of the protein in which amino acid sequences match to those considered 
amyloidogenic as proposed by Lopez de la Paz and Serrano (39). In the latter, the (*) indicates that 
this amino acid sequence is followed by a proline residue which is considered an amyloid fibril 
breaker.   
 
Fig. 7. A proposed model to describe differences in the process of fibril formation by proteins 
that follow a simple nucleation-dependent mechanism compared to fibril formation by κ-casein. In the 
nucleation-dependent mechanism, fibril formation commences with the unfolding of a native protein, 
forming a pool of partially folded intermediates, a process that is reversible. The partially folded 
intermediates are able to reversibly associate with each other until they reach a critical size/mass at 
which a stable nucleus is formed. The formation of this nucleus from the partially folded 
intermediates is slow and rate-limiting in the overall process of fibril formation. The time required for 
the formation of this nucleus is referred to as the lag phase which is protein concentration dependent 
since increasing the concentration increases the number of intermediates that can associate to form a 
nucleus. Fibril elongation then proceeds via the addition of intermediates to the growing nucleus. The 
mechanism also explains how seeding the reaction increases the reaction rate and decreases the lag 
phase since addition of preformed fibrils overcomes the time required to form nuclei (orange arrow) 
and the concentration of partially folded intermediates is not limiting. In contrast, fibril formation by 
κ-casein depends on the dissociation of a highly amyloidogenic species from its oligomeric state and 
this is the rate-limiting step in the fibril-forming pathway. Once released, these amyloidogenic species 
rapidly associate to form stable nuclei and, since the dissociation constant is independent of protein 
concentration, the lag phase of fibril formation by κ-casein is independent of the protein 
concentration. Fibril formation proceeds through a similar mechanism of β-sheet stacking as with the 
nucleation-dependent model, however, addition of preformed seeds to the reaction does not increase 
the reaction rate as the supply of the amyloidogenic species for fibril elongation is also limited by the 
dissociation constant (orange arrow).  
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Table 1: Estimations of secondary structural elements of RCMκ-CN before and after amyloid 
fibril formation as determined by FTIR analysis. 
 Before After 
 Peak (cm-1) Area (%) Peak (cm-1) Area (%) 
Side Chain 1612 10 1613 11 
β-structure 1628 17 1628 22 
   1639 9 
   1677 10 
Disordered 1648 48 1653 46 
Turns/Bends 1670 20   
 1685 4 1688 2 
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Table 2: Identification of peptide fragments of RCMκ-CN by time of flight mass 
spectrometry. 
Peptide source Matching 
tryptic peptide 
fragment 
Expected  
average mass  
[M+H]+ in Da 
Observed  
average massa  
[M+H]+ in Da 
Expected 
monoisotopic mass 
[M+H]+ in Da 
Observed 
monoisotopic massb  
[M+H]+ in Da 
Δ 
mass 
in ppm
Trypsin treated 
disaggregated 
fibrils 
Y[25-86]K 
Y[35-97]R 
7208.33 
7208.24 
7207.66  
 
 93 
80 
Y[35-68]R   4010.06 4009.90c 40 
S[69-86]K   1980.08 1980.03c 25 
Trypsin treated 
fibrils -  in-gel 
digest of 7 kDa 
SDS-PAGE band 
Y[25-34]R   1251.70 1251.70c 0 
Y[35-68]R   4010.06 4010.03 7 
S[87-111]K   2872.37d 2872.42 17 
F[17-34]R   2188.21 2188.22 5 
S[69-86]K   1980.08 1980.09 5 
Proteinase K 
treated fibrils – 
in-gel digest of 10 
kDa SDS-PAGE 
band Y[25-34]R   1251.70 1251.73 24 
Y[35-68]R   4010.06 4010.03 7 
F[17-34]R   2188.21 2188.22 5 
S[69-86]K   1980.08 1980.09 5 
Proteinase K 
treated fibrils –  
in-gel digest of 8 
kDa SDS-PAGE 
band 
Y[25-34]R   1251.70 1251.73 24 
a - data obtained in linear mode represent average masses of the [M+H]+-ions in Da 
b - data obtained in reflector mode represent monoisotopic masses of the [M+H]+-ions in Da 
c – the sequence identity of these peptides was confirmed using tandem mass spectrometry 
d – includes oxidation of two methionines to sulphoxides with subsequent mass change of 32.0 
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